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Bafilomycin A,, a selective inhibitor of vacuolar H’-ATPase, time- and dose-dependently induced the differentiation of Ml cells, a murine myeloid 
leukemic cell line, into macrophage-like cells as revealed by the phagocytosis of polystyrene latex particles. This differentiation was inhibited not 
only by actinomycin D and cycloheximide but also by ST-638 (an inhibitor of tyrosine kinase). However, it was affected neither by K-252a (an inhibitor 
of C-kinase) nor by H-89 (an inhibitor of A-kinase), in contrast to the Ml cell differentiation induced by leukemia inhibitory factor &IF). Okadaic 
acid inhibited both the bafilomycin A,-induced and LIF-induced differentiation of Ml cells. 
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1. Introduction 
Vacuolar H+-ATPases, a class of proton pump found 
on the membranes of acidic vacuolar compartments of 
eukaryotic cells such as lysosomes, endosomes, the Golgi 
complex, and secretory granules, including synaptic ves- 
icles, acidify the interior of these compartments [l]. They 
generate an electrochemical gradient of protons across 
vacuolar membranes, thus providing the driving force 
required to support the functions of endocytic and 
exocytic pathways, including the function of active trans- 
port [2]. However, it is not yet clear whether this vacuolar 
acidification regulates other cellular responses, such as 
cell proliferation and cell differentiation. 
Recently, we reported that bafilomycin A,, a potent 
selective inhibitor of the vacuolar H’-ATPases isolated 
from Streptomyces spp. [3,4], induced the differentiation 
of a cloned pheochromocytoma cell line, PC12 cells, into 
sympathetic neuron-like cells [5]. To elucidate key reac- 
tions in cell differentiation, we investigated whether 
bafilomycin A, induced differentiation in types of cells 
other than PC12, basing our study on these findings. 
In this study, we showed that bafilomycin A, also 
induced Ml cells, a murine myeloid leukemic cell line 
[&8], to differentiate into macrophage-like phagocytic 
cells; we also characterized, and, in the discussion, ex- 
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plored possible cascade(s) of information transmission 
common in M 1 cell differentiation (for phagocytic activ- 
ity) and PC12 cell differentiation (for neurite outgrowth). 
This work was presented in abstract form at the forty- 
fifth Annual Meeting of the Japan Society for Cell Biol- 
ogy [1992, Cell Struct. Funct. 17, 499a]. 
2. Materials and methods 
2.1. Materials 
Bafilomycin A, was kindly provided by Prof. K. Altendorf (Univer- 
sity of Osnabriick, Germany). Leukemia inhibitory factor (LIE 
ESGRO) was obtained from Wako Pure Chemical Industries, Inc. 
(Tokyo). ST-638 was kindly provided by Kanegafuchi Chemical Indus- 
try Co., Ltd. (Takasago, Japan). Polystyrene latex particles (average 
diameter 0.905 ,um) were obtained from Magsphere Inc. (MA, USA). 
The majority of the other reagents used were obtained from Sigma. 
2.2. Ceils and cell culture 
Ml cells (clone T22-3), kindly provided by Prof. K. Nagata (Kyoto 
University, Japan) [9], were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with penicillin (200 U/ml), streptomy- 
cin (100 @ml), and 10% heat-inactivated horse serum at 37°C under 
5% CO,-air. 
2.3. Determination of phagocytic activity 
Cells (2 x 10S/ml), incubated in the presence or absence of either 
bafilomycin A, or LIF, were harvested, resuspended in serum-free 
medium containing 0.2% polystyrene latex particles, and incubated for 
another 4 h. After being washed three times with PBS(-), cells contain- 
ing more than 5 latex particles were scored as phagocytic. More than 
200 cells per well were counted; the percentage of phagocytic ells was 
expressed as percent phagocytosis [6,10]. All the data shown are the 
averaged results (mean 5 S.D.) from duplicate xperiments. Cell viabil- 
ity was determined by the eosine dye exclusion test. 
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3. Results 
3.1. Ba~~~~yci~ A, induced phagocytosis of Ml cells 
When Ml cells were incubated in the presence of LIF, 
they acquired the phagocytic activity of differentiated 
phagocytic cells (macrophages), as shown in Fig. 1C. 
Similar phagocytic activity was induced when cells were 
incubated with bafilomycin A,, as shown in Fig. 1B. The 
number of phagocytized latex particles per phagocytic 
cell was similar in bafilomycin A,- and LIF-treated cells 
(Fig. 1). 
The bafilomycin A,-induced differentiation of Ml 
cells into phagocytic cells occurred time- and dose-de- 
pendently, as shown in Fig. 2. Induction of phagocytic 
activity required an 18 h incubation, the activity reaching 
a plateau in 24 h, when more than 50% of the cells were 
phagocytic. 
3.2. Induction of phagocytic activity by ba~~~~yei~ A, 
required de now synthesis of RNA and protein 
Actinomycin D inhibits the LIF-induced differentia- 
tion of Ml cells into macrophage-like phagocytic cells, 
suggesting its requirement for the de novo synthesis of 
RNA and, probably, proteins [6]. As shown in Fig. 3, 
both Actinomycin D and cycloheximide inhibited the 
induction of phagocytic activity evoked not only by LIF 
but also by bafilomycin A,, suggesting that such induc- 
tion of phagocytic activity is an active process requiring 
the de novo synthesis of both RNA and protein. 
3.3. Inhibitors of protein kinases and protein 
phosphatases affected the induction of phagocytic 
activity by ba~lo~yci~ A, 
Recent studies, in which various protein kinase and 
protein phosphatase inhibitors have been used, have sug- 
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gested that cellular differentiation depends on informa- 
tion transmission cascade(s) involving protein phospho- 
rylation [I ll1.51. The possible involvement of protein 
phosphorylation in the induction of phagocytic activity 
by bafilomycin A, was pursued in this study. As shown 
in Fig. 4, a protein tyrosine kinase inhibitor, ST-638, 
inhibited the induction of phagocytic activity evoked by 
both bafilomycin A, and LIF equally well. However, 
K-252a, a protein kinase C inhibitor, did not block the 
induction of phagocytic activity evoked by bafilomycin 
A,, but completely blocked that evoked by LIF at 200 
nM (Fig. 5A). Similarly, H-89, an inhibitor of protein 
kinase A, at concentrations (10 PM) of H-89 that 
strongly inhibited the effect of LIE marginally affected 
the induction of phagocytic activity evoked by bafilomy- 
tin A, (Fig. 5B). Further, dibutyryl cyclic AMP did not 
induce phagocytic activity in Ml cells at all (data not 
shown). These results suggest he involvement of protein 
tyrosine kinase, but not A- or C-kinases, in the induction 
of phagocytic activity by bafilomycin A,. Interestingly, 
okadaic acid, a protein serineithreonine phosphatase in- 
hibitor, also inhibited the induction of phagocytic activ- 
ity evoked by both LIF and bafilomycin A, (Fig. 6). 
suggesting either that the protein phosphorylation could 
be transient, or that a cyclic reaction of phosphorylation 
and dephosphorylation was required for the induction of 
phagocytic activity. 
4, Discussion 
The mechanism responsible for myelomonocytic dif- 
ferentiation has been studied with various inducers (e.g. 
LIF, inter1eukin-6) in myeloid leukemia cells of human 
(HL-60, K562) and mouse (Ml) origin. Accumulating 
Fig. 1. Phagocytic activity of Ml cells induced by bafilomycin A, and LIF. (A) control; (B) bafilomycin A, (50 nM): (C) LIF (150 units/ml). Cells 
were treated for 48 h. x 225. 
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Fig. 4. Effects of ST-638 on the induction of phagocytic activity by 
bafilomycin A, and LIF. Ml cells were incubated for 48 h with bafilo- 
mycin A, (50 nM) or LIF (150 units/ml) in the presence or absence of 
the indicated concentrations of ST-638. 
Fig. 2. Dose-response (A) and time-course (B) of bafilomycin A,- 
Induced phagocytic activity in Ml cells. (A) Cells were scored for 
phagocytic activity, as described in Section 2, after 48 h incubation with 
bafilomycin A,. Phagocytosis of control cells (without drugs) was less 
than 3%. DMSO (solvent for bafilomycin A,) did not induce phagocy- 
tosis, at a final concentration of 0.1% (v/v). (B) Cells were scored for 
phagocytic activity at the indicated times after the addition of bafilomy- 
tin A, (50 nM). 
kinase, since, at high concentrations, H-89 also inhibits 
various other protein kinases besides C-kinase [22]. 
Therefore, the results as a whole suggest hat K-252a- 
insensitive protein tyrosine kinase, but not A-, C-kinase, 
or K-252a-sensitive protein tyrosine kinase(s), partici- 
pates in the induction of phagocytic activity evoked by 
bafilomycin A,. On the other hand, okadaic acid would 
be expected to increase the level of protein phosphoryla- 
tion by suppressing protein phosphatase activity [23]. 
Therefore, the inhibitory effect of okadaic acid suggests 
that M 1 cell differentiation requires either transient pro- 
teins phosphorylation, or a continuous cycle of protein 
phosphorylation and dephosphorylation. 
These effects are quite similar to those seen with bafil- 
omycin A,-induced neurite outgrowth in PC12 cells ([15] 
and manuscript in preparation), suggesting a common 
information transmission pathway in PC12 and Ml cells. 
The results also suggest he possible participation, with 
regard to the effect of LIF, of an unknown K-252a- 
sensitive protein tyrosine kinase similar to the Trk-tyro- 
sine kinase that is required for nerve growth factor- 
evidence suggests that protein kinase C is involved in the 
differentiation induced by these agents [l&21]. How- 
ever, the precise requirements of intracellular signaling 
pathway(s) for the differentiation of myeloid into 
phagocytic cells have not yet been established. 
In this study, we showed that: (i) bafilomycin A, time- 
and dose-dependently induced Ml cells to differentiate 
into macrophage-like phagocytic cells; (ii) this differenti- 
ation was an active process requiring the de novo synthe- 
sis of RNA and protein, (iii) the process was inhibited by 
an inhibitor of tyrosine kinase (ST-638), but not by an 
inhibitor of C-kinase (K-252a) or A-kinase (H-89), in 
contrast to the LIF-induced differentiation and (iv) the 
process was also inhibited by a protein phosphatase in- 
hibitor (okadaic acid). 
The small inhibitory effect of H-89 on bafilomycin 
A,-induced phagocytic activity (Fig. 5B) might be ex- 
plained in terms of its possible effect on protein tyrosine 
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Fig. 3. Effects of actinomycin D (A) and cycloheximide (B) on the Fig. 5. Effects of K-252a (A) and H-89 (B) on the induction of 
induction of phagocytic activity by bafilomycin A, and LIF. Cells were phagocytic activity by bafilomycin A, and LIF. M 1 cells were incubated 
scored for phagocytic activity after 48 h incubation with bafilomycin for 48 h with bafilomycin A, (50 nM) or LIF (150 units/ml) in the 
A, (50 nM) or LIF (150 units/ml) in the presence or absence of the presence or absence of the indicated concentrations of K-252a and 
indicated concentrations of actinomycin D and cycloheximide. H-89. 
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Fig. 6. Effects of okadaic acid on the induction of phagocytic activity 
by bafilomycin A, and LIF. Ml cells were incubated for 48 h with 
bafilomycin A, (50 nM) or LIF (150 units/ml) in the presence or absence 
of the indicated concentrations of okadaic acid. 
induced neurite outgrowth. A similar conclusion has 
been reached for both LIF- and interleukin-6-induced 
myeloid leukemia differentiation, where the tyrosine 
phosphorylation of a 160 kDa protein has been reported 
as an essential step in mediating the early activation of 
MyD gene expression [ 131. Gp-130, a probable signal 
transducing component of high affinity LIF receptors 
[24,25], may be a mediator of such a protein tyrosine 
kinase reaction. 
Bafilomycin A, is a potent selective inhibitor of vacu- 
olar H’-ATPase [4]. The suppression of H’-ATPase ac- 
tivity results in an increase in lysosomal pH [5,26], the 
degree of this increase being similar to that evoked with 
NH&l, an agent that increases intra-vacuolar pH 
[27,28]. However, NH&l, even at 20 mM, neither in- 
duced phagocytic activity nor inhibited the induction of 
phagocytic activity by bafilomycin A, (our unpublished 
observation). This result shows that the increase in lyso- 
somal pH has nothing to do with the differentiation of 
Ml cells into phagocytic cells. This was also the case with 
the induction of neurite outgrowth in PC12 cells [5]. 
Furthermore, the results with PC12 cells (manuscript in 
preparation) indicate that cytoplasmic pH may also be 
unrelated to Ml cell differentiation. This raises a prob- 
lem regarding the primary action site of bafilomycin A, 
in cell differentiation: Namely, a cellular component 
other than vacuolar H’-ATPase might be a target of 
bafilomycin A,, suggesting that this agent is not specific 
for vacuolar H’-ATPase. In this case, protein tyrosine 
kinase (S-c, MAP-kinase-kinase, and others) or related 
structures may be the target. Alternatively, it is conceiv- 
able that subunits of vacuolar H+-ATPases have func- 
tions other than H’-pumping, such as involvement in the 
regulation of the induction of cell differentiation. 
Irrespective of its primary action site, bafilomycin A,, 
although it does not induce differentiation in cells that 
require proliferation (e.g. the erythroid cell differentia- 
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tion of Friend leukemia cells; unpublished observation), 
due to its growth inhibitory activity [29], should help us 
to elucidate the general cascade of information transmis- 
sion in cell differentiation. 
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